loader
Page is loading...
Print Logo Logo
dna helix


SPEAKERS

Deborah Pollack Milgate

Deborah Pollack-Milgate

Partner
Vice-Chair of the European Practice Group
Kristin Jones

Kristin Jones

President and CEO
Indiana Life Sciences Association
Mike Capaldi

Mike Capaldi

Executive Director
Institute for Gene Therapies
Laura McLinn

Laura McLinn

Founding President
Best Day Ever Foundation
Anna Katarzyna Talaga

Anna Katarzyna Talaga

Medical Director, Neurology Gene Therapy, Rare Disease
Pfizer



SPEAKERS

Deborah Pollack Milgate

Deborah Pollack-Milgate

Partner
Vice-Chair of the European Practice Group
Kristin Jones

Kristin Jones

President and CEO
Indiana Life Sciences Association
Mike Capaldi

Mike Capaldi

Executive Director
Institute for Gene Therapies
Laura McLinn

Laura McLinn

Founding President
Best Day Ever Foundation
Anna Katarzyna Talaga

Anna Katarzyna Talaga

Medical Director, Neurology Gene Therapy, Rare Disease
Pfizer

Gene therapy is at the forefront of new treatments, but there is still much to learn before these cutting-edge therapies become more mainstream.

Please join our panelists as they discuss:

  • What is gene therapy?
  • How different is the science?
  • How can gene therapy be used to address the unmet needs of rare diseases?
  • What is its potential impact on healthcare overall?
  • What changes need to be made by payers and healthcare systems to meet these challenges and opportunities?

There will not be a Zoom option for this session.  We are excited about getting back to our fully in-person meetings and hope you will be able to join us.

Networking and lunch
11:30 a.m.-noon

Program
Noon-1 p.m.

This program will feature a Q&A session. You may ask questions during the Q&A or submit them when you register.

Questions? Email Blakelee Kortz or call 317-231-7316.
Trending Connect
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.